The Detection of Drug-Resistant HIV-1 in Taiwan

NCT00690001 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 150

Last updated 2008-07-08

No results posted yet for this study

Summary

To assess the HIV resistance rate to variable antiretroviral agents in Taiwan, especially in patients with treatment failure, and to know the correlation between the drug resistance pattern and the HIV subtype, we will enroll a total of 150\~200 HIV-1-infected subjects to perform genotypic resistance testing and try to establish facility of phenotypic resistance testing.

Conditions

  • HIV Infections

Sponsors & Collaborators

  • National Taiwan University Hospital

    lead OTHER

Principal Investigators

  • Szu-Min Hsieh, M.D. · National Taiwan University Hospital

Eligibility

Min Age
20 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-04-30

Countries

  • Taiwan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00690001 on ClinicalTrials.gov